Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

512
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
512
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

680
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
680
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

874
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
874
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

541
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
541
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

367
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
367
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

326
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Reply.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis.

International journal of cardiology. Heart & vasculature·2025
Same author

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

EBioMedicine·2025
Same author

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.

The New England journal of medicine·2025
Same author

Effects of Prophylactic Oxytocin or Carbetocin on Troponin Release and Postpartum Haemorrhage at Planned Caesarean Delivery: A Double-Blind Randomised Controlled Trial.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

More STEMI patients should receive thrombolytic therapy.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2025

Related Experiment Video

Updated: Feb 27, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.8K

Morbidity outcomes after surgical aortic valve replacement.

Andreas Auensen1, Amjad Iqbal Hussain2, Bjørn Bendz1

  • 1Department of Cardiology, Faculty of Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Open Heart
|July 5, 2017
PubMed
Summary

Surgical aortic valve replacement (SAVR) improves survival and quality of life for severe aortic stenosis patients, but carries risks including cognitive decline and increased hospitalizations. Unoperated patients face poor outcomes.

Keywords:
Aortic valvne diseaseQuality of care and outcomesSurgery -valve

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.6K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K

Related Experiment Videos

Last Updated: Feb 27, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.8K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.6K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.9K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Severe symptomatic aortic stenosis (AS) often necessitates intervention.
  • Surgical aortic valve replacement (SAVR) is the standard treatment for patients with mild to moderate operative risk.
  • Understanding post-SAVR morbidity is crucial for comprehensive patient care.

Purpose of the Study:

  • To evaluate a wide range of morbidity outcomes following SAVR in patients with severe AS.
  • To compare outcomes between patients who underwent SAVR and those who did not.
  • To provide insights into the morbidity burden associated with modern SAVR.

Main Methods:

  • A cohort of 442 patients with severe AS was studied.
  • 351 patients underwent SAVR; 91 did not.
  • Evaluations included the 6-minute walk test (6MWT), NYHA and CCS class, HRQoL, MMSE, and myocardial remodeling. Adverse events and mortality were recorded.

Main Results:

  • Three-year survival after SAVR was 90.0%.
  • SAVR improved NYHA class, CCS score, HRQoL, and induced reverse ventricular remodeling.
  • SAVR was associated with a decrease in 6MWT, increased major adverse cardiovascular events (13.5%), all-cause hospitalizations (62.4 per 100 patient-years), and cognitive disability (3.2% to 8.8%). 49.1% achieved NYHA class I at 1 year.

Conclusions:

  • SAVR offers significant survival and functional benefits for severe AS patients.
  • However, SAVR is linked to a notable morbidity burden, including cognitive impairment.
  • Unoperated patients exhibit a poor prognosis, underscoring the importance of timely intervention.